GEOGRAPHIC ATROPHY OF THE MACULA

Clinical trials for GEOGRAPHIC ATROPHY OF THE MACULA explained in plain language.

Never miss a new study

Get alerted when new GEOGRAPHIC ATROPHY OF THE MACULA trials appear

Sign up with your email to follow new studies for GEOGRAPHIC ATROPHY OF THE MACULA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New eye injection aims to halt blinding disease

Disease control Ongoing

This study is testing a new drug called AVD-104, given as an injection into the eye, for people with geographic atrophy (GA), a severe form of age-related macular degeneration that causes progressive vision loss. The main goal is to see if the drug is safe and if it can slow down…

Matched conditions: GEOGRAPHIC ATROPHY OF THE MACULA

Phase: PHASE2 • Sponsor: Aviceda Therapeutics, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

GEOGRAPHIC ATROPHY OF THE MACULA

Get alerted when new GEOGRAPHIC ATROPHY OF THE MACULA trials appear

New eye injection aims to halt blinding disease